NovaBridge Biosciences (NBP) Retained Earnings (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Retained Earnings data on file, last reported at -$80.2 million in Q4 2025.

• Quarterly Retained Earnings fell 180.18% year-over-year to -$80.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$80.2 million (down 180.18% YoY) and the FY2025 annual result came in at -$80.2 million, down 180.18% from the prior year.
• Retained Earnings advanced to -$80.2 million in Q4 2025 per NBP's latest filing, from -$1.3 billion in the prior quarter.
• Across five years, Retained Earnings topped out at $41.4 million in Q4 2023 and bottomed at -$681.1 billion in Q4 2021.
• The 5-year median for Retained Earnings is -$1.1 billion (2023), against an average of -$53.1 billion.
• The widest annual swing landed in 2021, when Retained Earnings plunged 8887020.65%; it then soared 100.0% in 2022.
• Tracing NBP's Retained Earnings over 5 years: stood at -$681.1 billion in 2021, then soared by 100.0% to $30.1 million in 2022, then surged by 37.82% to $41.4 million in 2023, then plunged by 169.08% to -$28.6 million in 2024, then plunged by 180.18% to -$80.2 million in 2025.
• Per Business Quant, the three latest NBP Retained Earnings figures stand at -$80.2 million (Q4 2025), -$1.3 billion (Q3 2025), and -$1.3 billion (Q2 2025).

Peer Comparison